Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Artificial Intelligence
Biotech
iBio champions AI-fueled obesity pivot as 1st asset hits clinic
Upon finally reaching the clinic, iBio feels vindicated about the artificial intelligence-powered discovery platform it picked up in 2022.
Fraiser Kansteiner
Jun 26, 2026 5:00am
With $15M, BI becomes latest to buy into Immunai’s AI platform
Jun 25, 2026 9:00am
Icon names Microsoft tech partner as Q1 results grow confidence
Jun 24, 2026 3:10pm
Sanofi, Pangaea in pact to detect underdiagnosed genetic disease
Jun 22, 2026 9:00am
Insilico lands backloaded $2.5B AI deal with SK Biopharm
Jun 22, 2026 12:30am
How Daiichi Sankyo plans to stay ahead in the ADC game
Jun 17, 2026 6:00pm
